Syon Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Syon Capital's LLY Position: Q3 2026 in Review
Syon Capital increased its Eli Lilly (LLY) stake by 17% in Q3 2026, buying an estimated $2.63M and bringing the position to 15,364 shares worth $17.8M. The position accounts for 0.62% of the portfolio, ranked #28.
Syon Capital first reported a position in LLY in Q3 2023 and has held it in 13 quarters since. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Syon Capital held 15,364 shares of Eli Lilly worth $17.8M as of Q3 2026.
- Syon Capital bought 2,229 Eli Lilly shares in Q3 2026, an estimated $2.63M.
- Eli Lilly made up 0.62% of Syon Capital's portfolio in Q3 2026, its #28 holding.
- Syon Capital first reported a position in Eli Lilly in Q3 2023 and has held it in 13 quarters since.
- 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Syon Capital's 13F filing for Q3 2026, filed 16 Nov 2026.